Literature DB >> 24057178

Associations between endothelial nitric oxide synthase A/B, angiotensin converting enzyme I/D and serotonin transporter L/S gene polymorphisms with pulmonary hypertension in COPD patients.

Sevinc Sarinc Ulasli1, Fusun Oner Eyuboglu, Hasibe Verdi, Fatma Belgin Atac.   

Abstract

Different biochemical pathways and cellular mechanisms play role in the pathogenesis of pulmonary hypertension (PH) in chronic obstructive pulmonary disease (COPD). Alveolar hypoxia is not the only determinant of vascular remodeling, genetic factors are thought to have additive effects. We aimed to investigate the effects of endothelial nitric oxide synthase (eNOS A/B), angiotensin converting enzyme (ACE I/D) and serotonin transporter (5-HTT L/S) gene polymorphisms on development and severity of PH in COPD patients. 50 COPD patients without PH (group 1); 30 COPD patients with PH confirmed with echocardiography (group 2) and 49 healthy subjects (group 3) as control group were included to the study. eNOS A/B, ACE I/D and 5-HTT L/S gene polymorphisms and allele frequencies of COPD patients with and without PH and healthy subjects were determined. Functional parameters and echocardiographic measurements were recorded. Patients with PH were also assessed in two subgroups according to the severity of pulmonary arterial pressure (PAP). Significant differences among three groups in the distribution of 5-HTT genotype and allele frequency were present (respectively p = 0.002; p = 0.021). In group 2, LL and LS genotype rate was 93.3 % with a frequency of 71.2 % L allele and 28.3 % of S allele. 5-HTT LL genotype was present in 88.9 % of patients with PAP ≥50 mmHg significantly (p = 0.012). Other genotype distributions were not significantly different between two subgroups. The results of this study can suggest that COPD patients with L allele of 5-HTT may have higher risk for the development of PH and patients with LL genotype of 5-HTT may present higher PAP. We also demonstrated that eNOS and ACE gene polymorphisms were not associated with the development and severity of PH in our study population. Further studies with larger numbers of patients are needed to explore these relationships.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24057178     DOI: 10.1007/s11033-013-2664-6

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  37 in total

1.  Standardisation of the single-breath determination of carbon monoxide uptake in the lung.

Authors:  N Macintyre; R O Crapo; G Viegi; D C Johnson; C P M van der Grinten; V Brusasco; F Burgos; R Casaburi; A Coates; P Enright; P Gustafsson; J Hankinson; R Jensen; R McKay; M R Miller; D Navajas; O F Pedersen; R Pellegrino; J Wanger
Journal:  Eur Respir J       Date:  2005-10       Impact factor: 16.671

2.  Angiotensin-converting enzyme and angiotensinogen gene polymorphisms, plasma levels, cardiac dimensions. A twin study.

Authors:  A Busjahn; H Knoblauch; M Knoblauch; J Bohlender; M Menz; H D Faulhaber; A Becker; H Schuster; F C Luft
Journal:  Hypertension       Date:  1997-01       Impact factor: 10.190

3.  Noninvasive estimation of both systolic and diastolic pulmonary artery pressure from Doppler analysis of tricuspid regurgitant velocity spectrum in patients with chronic heart failure.

Authors:  Luca Lanzarini; Alessandra Fontana; Elena Lucca; Carlo Campana; Catherine Klersy
Journal:  Am Heart J       Date:  2002-12       Impact factor: 4.749

Review 4.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms.

Authors:  N B Schiller; P M Shah; M Crawford; A DeMaria; R Devereux; H Feigenbaum; H Gutgesell; N Reichek; D Sahn; I Schnittger
Journal:  J Am Soc Echocardiogr       Date:  1989 Sep-Oct       Impact factor: 5.251

5.  Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation.

Authors:  P G Yock; R L Popp
Journal:  Circulation       Date:  1984-10       Impact factor: 29.690

6.  The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants.

Authors:  M Nakamura; S Ueno; A Sano; H Tanabe
Journal:  Mol Psychiatry       Date:  2000-01       Impact factor: 15.992

7.  Repeat length polymorphism of the serotonin transporter gene influences pulmonary artery pressure in heart failure.

Authors:  Thomas P Olson; Eric M Snyder; Robert P Frantz; Stephen T Turner; Bruce D Johnson
Journal:  Am Heart J       Date:  2007-03       Impact factor: 4.749

8.  The link between angiotensin-converting enzyme genotype and pulmonary artery pressure in patients with COPD.

Authors:  Ruzena Tkácová; Pavol Joppa; Branislav Stancák; Ján Salagovic; Silvia Misíková; Ivan Kalina
Journal:  Wien Klin Wochenschr       Date:  2005-03       Impact factor: 1.704

9.  Cloning and structural characterization of the human endothelial nitric-oxide-synthase gene.

Authors:  K Miyahara; T Kawamoto; K Sase; Y Yui; K Toda; L X Yang; R Hattori; T Aoyama; Y Yamamoto; Y Doi
Journal:  Eur J Biochem       Date:  1994-08-01

10.  Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese.

Authors:  K Nakai; C Itoh; Y Miura; K Hotta; T Musha; T Itoh; T Miyakawa; R Iwasaki; K Hiramori
Journal:  Circulation       Date:  1994-11       Impact factor: 29.690

View more
  5 in total

Review 1.  Genetic Polymorphism of Angiotensin-Converting Enzyme and Chronic Obstructive Pulmonary Disease Risk: An Updated Meta-Analysis.

Authors:  Sang Wook Kang; Su Kang Kim; Joo-Ho Chung; Hee-Jae Jung; Kwan-Il Kim; Jinju Kim; Ju Yeon Ban
Journal:  Biomed Res Int       Date:  2016-10-18       Impact factor: 3.411

2.  Analysis of Angiotensin Converting Enzyme, Endothelial Nitric Oxide Synthase & Serotonin Gene Polymorphisms among Atrial Septal Defect Subjects with and without Pulmonary Arterial Hypertension.

Authors:  Nur Ilyana Jaafar; Ramachandran Vasudevan; Patimah Ismail; Ahmad Fazli Abdul Aziz; Nur Afiqah Mohamad; Geetha Kandavello; Raja Nurzatul Effah Raja Adnan; Vinod Balasubramaniam
Journal:  J Cardiovasc Dev Dis       Date:  2018-09-18

3.  Association of angiotensin-converting enzyme gene I/D polymorphism with chronic obstructive pulmonary disease: a meta-analysis.

Authors:  Guodong Xu; Guohui Fan; Yingtong Sun; Lili Yu; Sinan Wu; Wenquan Niu
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2018 Apr-Jun       Impact factor: 1.636

4.  ACE gene polymorphism is associated with COPD and COPD with pulmonary hypertension: a meta-analysis.

Authors:  Yao Ma; Xiang Tong; Ying Liu; Sitong Liu; Hai Xiong; Hong Fan
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-08-13

5.  SLC6A4 gene L/S polymorphism and susceptibility to pulmonary arterial hypertension: a meta-analysis.

Authors:  Feng Zhang; Meiming Yang; Ting Xiao; Yan Hua; Yu Chen; Shasha Xu; Chunping Ni
Journal:  J Int Med Res       Date:  2020-09       Impact factor: 1.671

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.